Immediate Impact
11 standout
Citing Papers
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Gastric cancer treatment: recent progress and future perspectives
2023 Standout
Works of Y. Tojima being referenced
Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Y. Tojima | 290 | 153 | 4 | 67 | 5 | 313 | |
| Paul Sitzler | 228 | 140 | 4 | 39 | 9 | 272 | |
| April S. Tignor | 314 | 223 | 6 | 73 | 7 | 370 | |
| D. Dymecki | 242 | 242 | 4 | 114 | 9 | 339 | |
| S. Mucci-Hennekinne | 235 | 143 | 6 | 65 | 9 | 272 | |
| Jean-Pierre Saey | 210 | 171 | 6 | 94 | 5 | 318 | |
| Ch. Wullstein | 277 | 117 | 5 | 145 | 8 | 314 | |
| Nils Breuer | 321 | 157 | 7 | 124 | 5 | 332 | |
| R. Muench | 277 | 155 | 7 | 57 | 8 | 297 | |
| Charan Donkor | 266 | 139 | 10 | 143 | 8 | 370 | |
| Ernest Max | 212 | 175 | 4 | 72 | 8 | 270 |
All Works
Loading papers...